Allison Eberly

Assistant Professor

Washington University in Saint Louis School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Allison Eberly is an Assistant Professor at Washington University in St Louis School of Medicine, United States. Her research primarily focuses on the detection of antimicrobial resistance, the behavior of anaerobic bacteria, and the impact of various bacterial infections on health outcomes. Recent publications highlight her work on innovative methods for identifying carbapenemase production and the performance of PCR assays for SARS-CoV-2 detection.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Maria Hadjifrangiskou

Associate Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Supavit Chesdachai

Infectious Diseases Fellow and Assistant Professor of Medicine

Mayo Clinic

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Allison Eberly

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Development and Validation of a Novel Anaerobic Carbapenem Inactivation Method (Ana-CIM) for the Detection of Carbapenemase Production in Bacteroides fragilis.

Lord of the "rings": A case of <i>Plasmodium falciparum</i>.

Understanding and Application of Daptomycin-Susceptible Dose-Dependent Category for <i>Enterococcus</i>: A Mixed-Methods Study.

A tale of two unusual anaerobic bacterial infections in an immunocompetent man: A case report and literature review.

Answer to December 2021 Photo Quiz.

Photo Quiz: You Get What You Get, and Sometimes It's Tuberculate.

Performance of three polymerase chain reaction-based assays for detection of SARS-CoV-2 in different upper respiratory tract specimens.

Cytochrome bd promotes Escherichia coli biofilm antibiotic tolerance by regulating accumulation of noxious chemicals.

Initial SARS-CoV-2 PCR crossing point does not predict hospitalization and duration of PCR positivity.

Data highlighting phenotypic diversity of urine-associated <i>Escherichia coli</i> isolates.

Collaborators (2)

Maria Hadjifrangiskou

Supavit Chesdachai

Make your next move.